小儿腹泻贴佐治小儿腹泻的临床研究

发布时间：2018-09-06 18:11

【摘要】：目的：观察小儿腹泻贴辅佐治疗小儿风寒泻、寒湿泻及脾虚泻的临床疗效,并对小儿腹泻贴的临床疗效做出客观评价。方法：将腹泻患儿90例随机分为治疗组60例及对照组30例。两组患儿均常规服用思密达,治疗组在此基础上加用小儿腹泻贴敷脐,连续用药3天为1个疗程。观察时间为1-2个疗程,观察治疗效果、治疗前后主症积分、症候总积分变化及比较治愈时间的长短。结果：疗效评定方面,治疗组疾病愈显率95.00%(57/60),高于对照组76.67%(23/30),差异有统计学意义(P0.05)。治疗组治疗后主症积分为(0.50±1.33)分,低于对照组的(1.17±1.32)分,差异有统计学意义(P0.05)；治疗组治疗后症状总积分为(0.58±1.38)分,低于对照组的(1.40±1.48)分,差异有统计学意义(P0.05),治疗组治愈时间为(94.50±25.44)h,短于对照组治愈时间(120.00±37.95)h,差异有统计学意义(P0.05)。结论：小儿腹泻贴辅助思密达治疗小儿腹泻,能够提高临床疗效,缩短病程,优于单纯思密达对照组,且经济方便,具有无创性,易于患儿和家长接受,说明小儿腹泻贴值得临床推广应用。
[Abstract]:Objective: to observe the clinical effect of infantile diarrhea paste in treating children with wind-cold diarrhea, cold-dampness diarrhea and spleen asthenia diarrhea, and to evaluate objectively the clinical effect of infantile diarrhea paste. Methods: 90 children with diarrhea were randomly divided into treatment group (n = 60) and control group (n = 30). Two groups of children were routinely taken smecta, the treatment group on this basis, plus the application of diarrhea navel, 3 days of treatment as a course of treatment. Observation time is 1-2 courses, observe the therapeutic effect, the main symptom integral, the symptom total integral change and compare the cure time before and after treatment. Results: in the evaluation of curative effect, the curative effect rate of the treatment group was 95.00% (57 / 60), which was higher than that of the control group 76.67% (23 / 30), the difference was statistically significant (P0.05). After treatment, the score of main symptom in the treatment group was (0.50 卤1.33), lower than that in the control group (1.17 卤1.32), the difference was statistically significant (P0.05), the total score of symptoms after treatment in the treatment group was (0.58 卤1.38), lower than that in the control group (1.40 卤1.48). The difference was statistically significant (P0.05), the cure time of the treatment group was (94.50 卤25.44) h, shorter than that of the control group (120.00 卤37.95) h, the difference was statistically significant (P0.05). Conclusion: the treatment of infantile diarrhea with infantile diarrhea paste assisted by smecta can improve the clinical efficacy and shorten the course of disease. It is superior to the simmeida control group. It is economical and convenient. It is easy to be accepted by children and parents. It shows that the children diarrhea paste is worth popularizing and applying in clinic.
【学位授予单位】：南京中医药大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：R272

【参考文献】